Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-28
2006-03-28
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S095000, C514S096000, C514S099000, C514S100000, C514S101000, C514S437000, C514S443000, C514S444000, C514S445000, C514S447000, C514S448000, C514S454000, C514S455000, C514S465000, C514S466000, C514S469000, C514S470000, C514S471000, C514S472000, C549S005000, C549S006000, C549S026000, C549S027000, C549S051000, C549S054000, C549S055000, C549S057000, C549S058000, C549S059000, C549S060000, C549S061000, C549S063000, C549S064000, C549S065000, C549S068000, C549S069000, C549S071000, C549S072000, C549S074000, C549S
Reexamination Certificate
active
07019024
ABSTRACT:
The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of the formula:or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 3929813 (1975-12-01), Higuchi et al.
patent: 4383999 (1983-05-01), Bondinell et al.
patent: 4514414 (1985-04-01), Bondinell et al.
patent: 4639468 (1987-01-01), Roncucci et al.
patent: 4772615 (1988-09-01), Pavia
patent: 4931450 (1990-06-01), Sonnewald
patent: 5010090 (1991-04-01), Gronvald et al.
patent: 5837730 (1998-11-01), Javitt
patent: 6667336 (2003-12-01), Wang et al.
patent: 885 303 (1981-03-01), None
patent: 2144475 (1995-03-01), None
patent: 30 10 599 (1980-10-01), None
patent: 0 066 456 (1982-12-01), None
patent: 0 068 544 (1983-01-01), None
patent: 0 221 572 (1987-05-01), None
patent: 0 231 996 (1987-08-01), None
patent: 0 672 661 (1995-09-01), None
patent: 0 672 677 (1995-09-01), None
patent: 672 677 (1995-09-01), None
patent: 02129158 (1990-05-01), None
patent: WO 95/04072 (1995-02-01), None
Beal, M. F., Aging, Energy, and Oxidative Stress in Neurodegenerative Diseases, Annals of Neurology, vol. 38, No. 3, pp. 357-386, Sep. 1995.
Edlund, P. O., Identification of Amperozide Metabolites in Urine from Rats, Rabbits, Dogs and Man by Frit-FAB LC/MS Using Deuterated Solvents to Gain Additional Structural Information, Journal of Mass Spectrometry, vol. 30, pp. 1380-1392, 1995.
Inayama et al., A Rapid and Simple Screening Method for Methamphetamine in Urine by Radioimmunoassay using a I-Labeled Methamphetamine Derivative, Chemical & Pharmaceutical Bulletin, vol. 28, No. 9, pp. 2779-2782, Sep. 1980.
Lehmann, J., Synthese Dihydroxylierter Diphenylalkylamine Uber Azalactone, Archiv der Pharmazie, Vo.. 316, No. 4, pp. 339-346, Apr. 1983.
Lewis et al., Photochemical Addition of Tertiary Amines to Stilbene. Free-Radical and Electron-Transfer Mechanisms for Amine Oxidation, Journal of the American Chemical Society, vol. 104, No. 7, pp. 1924-1929, Apr. 1982.
Grant & Hackh's Chemical Dictionary, pp. 366, 408, 415, 416 and 587, 1987.
Cecil et al., Textbook of Medicine, pp. 1992-1994, 1996.
Reyna J. Simon et al.,Proc. Natl. Acad. Sci. USA, 89:9367-9371 (1992(.
Fadia E. Ali et al.,J. Med. Chem., 28:653-660 (1985).
Michael R. Pavia et al.,J. Med. Chem., 35:4238-4248 (1992).
Computer Database Search, Search I, Feb. 1996.
Computer Database Search, Search II, 1996.
Computer Database Search, Search III, 1996.
Computer Database Search, Search IV, 1996.
Computer Database Search, Search V, 1995.
Computer Database Search, Search VI, Oct. 1995.
Computer Database Search, Search VII, 1996.
Bell Stanley Charles
Borden Laurence A.
Ognyanov Vassil Iliya
Zhang Jing
Allelix Neuroscience Inc.
Coleman Brenda
Law Offices of Arthur E. Jackson
LandOfFree
Pharmaceutical for treatment of neurological and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical for treatment of neurological and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical for treatment of neurological and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3583494